Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology ...

Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis over ...

Good afternoon, everyone, and welcome to the Superior Group of Companies' Third Quarter 2025 Conference Call. With us today are Michael Benstock, Chief Executive Officer; and Mike Koempel, President ...

Revenue 1 of $2.3 billion was flat compared to prior-year quarter due to the sale of TRANZACT Organic Revenue growth of 5% for the quarter ...

Third Quarter 2025 Highlights (Thirteen weeks ended September 27, 2025) Net sales increased 8.0% to a record $424.9 million compared to $393.3 million in the prior year quarter Net income totaled ...

Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsCamilla Zuckero - Vice President of Investor ...

There isn’t a day that goes by without a question about private market assets landing on my desk. Recordkeepers, advisors, consultants, and plan sponsors are all asking the same two things: Should we ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results ...

FormFactor, Inc. (Nasdaq: FORM) today announced its financial results for the third quarter of fiscal 2025 ended September 27, 2025. Quarterly revenues were $202.7 million, an increase of 3.5% ...

This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...